Acta Vet. Brno 2021, 90: 191-200
https://doi.org/10.2754/avb202190020191
Determining the expression levels of circulating tumour cell markers in canine mammary tumours
References
1. 2014: Clinicopathologic implications of EpCAM and Cox2 expression in breast cancer. Clin Breast Cancer 14: 1-9
< NMR, Abd El-Rehim DM https://doi.org/10.1016/j.clbc.2013.09.006>
2. 2010: Circulating tumor cells in clinical practice: Methods of detection and possible characterization. Methods 50: 289-297
< M, Sandri MT https://doi.org/10.1016/j.ymeth.2010.01.027>
3. 1985: Regulation of the epidermal growth factor receptor by phosphorylation. J Cell Biochem 29: 195-208
< PJ, Weber W, Cocher C, Gill GN https://doi.org/10.1002/jcb.240290304>
4. 2011: Validation of candidate reference genes for normalization of quantitative PCR in bovine mammary epithelial cells responding to inflammatory stimuli. J Dairy Sci 94: 2425-2430
< S, Cunha P, Gilbert FB, Meurens F, Rainard P https://doi.org/10.3168/jds.2010-3859>
5. 2019: Canine mammary tumors: comparison of classification and grading methods in a survival study. Vet Pathol 56: 208-219
< A, França M, Pereira C, Vilaça R, Vilhena H, Tinoco F, Silva MJ, Ribeiro J, Medeiros R, Oliveira P, Dias-Perreira P, Santos M https://doi.org/10.1177/0300985818806968>
6. 2013: EGFR and microvessel density in canine malignant mammary tumours. Res Vet Sci 95: 1094-1099
< MI1, Guimarães MJ, Pires I, Prada J, Silva-Carvalho R, Lopes C, Queiroga FL https://doi.org/10.1016/j.rvsc.2013.09.003>
7. 2011: Potential marker for detection of circulating canine mammary tumor cells in the peripheral blood. Vet J 190: 165-168
< A, Oliveira JT, Gärtner F, Kohn B, Gruber AD, Klopfleisch R https://doi.org/10.1016/j.tvjl.2010.09.027>
8. 2013: Multiple RT-PCR markers for detection of circulating tumour cells of metastatic canine mammary tumours. Vet J 196: 34-39
< A, Kohn B, Gruber AD, Kolpfleisch R https://doi.org/10.1016/j.tvjl.2012.08.021>
9. 1993: Receptors for estrogen, progesterone and epidermal growth factors in normal and tumorous canine mammary tissues. J Reprod Fertil Suppl 47: 501-512
I, Rauis J, Wouters-Ballman P, Devleeschouwer N, Leclerq G, Verstegen JP
10. 2009: The relationship between tumour size and expression of prognostic markers in benign and malignant canine mammary tumours. Vet Comp Oncol 7: 230-235
< E, Bertagnolli AC, Cavalcanti MF, Schmitt FC, Cassali GD https://doi.org/10.1111/j.1476-5829.2009.00193.x>
11. 2009: Immonuhistochemical expression of EGFR in canine mammary tissues. Res Vet Sci 87: 432-437
< A, Gartner F, Alves A, Schmitt F https://doi.org/10.1016/j.rvsc.2009.04.016>
12. 2017: EpCAM and COX2 expression are positively correlated in human breast cancer. Mol Med Rep 15: 3755-3760
< S, Sun Y, Liu X, Zhang D, Yang X https://doi.org/10.3892/mmr.2017.6447>
13. 2020: Expression and function of epithelial cell adhesion molecule EpCAM: where are we after 40 years? Cancer Metastasis Rev 39: 969-987
< O, Pan M, Schinke H, Canis M, Baeuerle PA https://doi.org/10.1007/s10555-020-09898-3>
14. 2011: Classification and grading of canine mammary tumors. Vet Pathol 48: 117-131
< M, Pena L, Rasotto R, Zappulli V https://doi.org/10.1177/0300985810393258>
15. 2014: Concurrent expression of cyclo-oxygenase-2 and epidermal growth factor receptor in canine malignant mammary tumours. J Comp Pathol 150: 27-34
< MJ, Carvalho MI, Pires I, Prada J, Gonzales Gil A, Lopes C, Queiroga FL https://doi.org/10.1016/j.jcpa.2013.07.005>
16. 2016: Clinical staging in bitches with mammary tumors: Influence of type and histological grade. Can J Vet Res 80: 318-322
LF, de Araùjo CP, Blanca WT, Guimaraes EC, Medeiros AA
17. 2016: Longitudinal claudin gene expression analyses in canine mammary tissues and thereof derived primary cultures and cell Lines. Int J Mol Sci 17: 1655
< SC, Becker A, Rateitschak K, Mohr A, Lüder Ripoli F, Hennecke S, Junginger J, Hewicker-Trautwein M, Brenig B, Ngezahayo A, Nolte I, Murua Escobar H https://doi.org/10.3390/ijms17101655>
18. 2011: Identification of stable and oestrus cycle-independent housekeeping genes in the rat mammary gland and other tissues. Vet J 190: 103-108
< H, Ekstrom CT, Veinberg S, Oleksiewicz MB, Klopfleisch R https://doi.org/10.1016/j.tvjl.2010.09.002>
19. 2021: Wounds inhibit tumor growth in vivo. Ann Surg 273: 173-180
< MS, Maan ZN, Leavitt T, Hong WX, Rennert RC, Marshall CD, Borrelli MR, Zhu TN, Esquivel M, Zimmermann A, McArdle A, Chung MT, Foster DS, Jones RE, Gurtner GC, Giaccia AJ, Lorenz HP, Weissman IL, Longaker MT https://doi.org/10.1097/SLA.0000000000003255>
20. 2008: Expression of claudin-1, -2, -3, -4, -5 and -7 proteins in benign and malignant canine mammary gland epithelial tumours. J Comp Pathol 139: 238-245
< C, Halász J, Szász AM, Kiss A, Schaff Z, Rusvai M, Gálfi P, Kulka J https://doi.org/10.1016/j.jcpa.2008.08.001>
21. 2018: Current biomarkers of canine mammary tumors. Acta Vet Scand 60: 66
< I, Ruszczak A, Kanafa S, Kacprzak K, Krol M, Jurka P https://doi.org/10.1186/s13028-018-0417-1>
22. 2011: Epidermal growth factor enhance the malignant phenotype in canine mammary carcinoma cell lines. Vet Comp Oncol 9: 196-206
< KC, Qurollo BA, Rose BJ, Thamm DH https://doi.org/10.1111/j.1476-5829.2010.00248.x>
23. 2005: Clinical evaluation of the complications found in bitches after total bilateral mastectomy operations. Med Weter 61: 507-509
I, Ucmak M, Apaydin S
24. 2018: Tyrosine kinase expression analyses in canine mammary gland tumours - a pilot study. Acta Vet Hung 66: 294-308
< Z, Szabó B, Jakus J, Vajdovich P https://doi.org/10.1556/004.2018.027>
25. 2003: Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene 22: 2021-2033
< SL, Argani P, Korz D, Evron E, Raman V, Garrett E, Rein A, Sauter G, Kallioniemi O, Sukumar S https://doi.org/10.1038/sj.onc.1206199>
26. 2011: Detection of EPCAM positive and negative circulating tumor cells in metastatic breast cancer patients. Acta Oncol 50: 700-710
< R, Obermayr E, Bises G, Pfeiler G, Gneist M, Wrba F, de Santis M, Zeillinger R, Hudec M, Dittrich C https://doi.org/10.3109/0284186X.2010.549151>
27. 2018: Cancer panel analysis of circulating tumor cells in patients with breast cancer. Oncol Lett 16: 612-618
CH, Lee SJ, Choi SH, Ahn SH, Son BH, Lee JW, Yu JH, Kwon NJ, Lee WC, Yang KS, Lee DH, Han DY, Choi MS, Park P, Lee HK, Kim MS, Lee J, Jeon BH
28. 2016: Expression of epithelial cell adhesion molecule and molecular subtypes and prognosis of breast cancer. Zhong Nan Da Xue Xue Bao Yi Xue Ban 41: 258-263
X, Fu L, Liu M, Fu M
29. 2009: Claudin-7 regulates EpCAM-mediated functions in tumor progression. Mol Cancer Res 7: 285-299
< T, Preobraschenski J, Tuncay H, Weiss T, Kuhn S, Ladwein M, Langbein L, Zöller M https://doi.org/10.1158/1541-7786.MCR-08-0200>
30. 2008: Reduced expression of the claudin-7 gene correlates with venous invasion and liver metastasis in colorectal cancer. Oncol Rep 19: 953-959
T, Kunisaki C, Yoshihara K, Yamada R, Yamamoto N, Sato T, Makino H, Yamagishi S, Nagano Y, Fujii S, Shiozawa M, Akaike M, Wada N, Rino Y, Masuda M, Tanaka K, Imada T
31. Owen LN 1980: Clinical stages (TNM) of canine mammary tumors. In: Owen LD (Ed.): TNM Classification of Tumors in Domestic Animals. World Health Organization, Switzerland, pp. 16-18
32. 2014: Crystal structure and its bearing towards an understanding of key biological functions of EpCAM. Nat Commun 5: 4764
< M, Gunčar G, Djinović-Carugo K, Lenarčič B https://doi.org/10.1038/ncomms5764>
33. 2017: Quantification of epidermal growth factor receptor (EGFR) in canine mammary tumours by ELISA assay: clinical and prognostic implications. Vet Comp Oncol 15: 383-390
< FL, Perez-Alenza MD, Gonzalez-Gil A, Silvan G, Pena L, Illera JC https://doi.org/10.1111/vco.12174>
34. 2015: EpCAM based capture detects and recovers circulating tumor cells from all subtypes of breast cancer except claudin-low. Oncotarget 6: 44623-4434
< A, Mineyev N, Zhu W, Park E, Lomas C, Punj V, Yu M, Barrak D, Forte V, Porras T, Tripathy D, Lang JE https://doi.org/10.18632/oncotarget.5977>
35. 2005: Reduced expression of claudin-7 in fine needle aspirates from breast carcinomas correlate with grading and metastatic disease. Cytopathology 16: 193-198
< T, Pedersen MK, Ebeltoft K, Naess O https://doi.org/10.1111/j.1365-2303.2005.00257.x>
36. 2011: Canine mammary tumours, an overview. Reprod Domest Anim 46: 1112-1131
< N, Rooster H, Veldhuis Kroeze EJB, Van Ginneken C, Van Brantegem L https://doi.org/10.1111/j.1439-0531.2011.01816.x>
37. 2013: EPCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2(+), basal-like and HER2 intrinsic subtypes of breast cancer. Br J Cancer 108: 1480-1487
< SD, Muenst S, Barbie T, Fleming T, Gao F, Spizzo G, Oertli D, Viehl CT, Obermann EC, Gillanders WE https://doi.org/10.1038/bjc.2013.80>
38. 1984: Epidermal growth factor: structure, location, phosphorylation and regulation of its receptor. Biochimie 66: 515-530
< R, Chabot JG, Pelletier G, Labrie F, Walker P https://doi.org/10.1016/0300-9084(84)90146-9>
39. 1990: Association of the 323/A3 surface glycoprotein with tumor characteristics and behavior in human breast cancer. Cancer Res 50: 3317-3321
AK, Clark GM, Chamness GC, McGuire WL
40. 2012: Overexpression of epitethelial growth factor receptor (EGFR) predicts better response to neo-adjuvant chemotheraphy in patients with triple-negative breast cancer. J Transl Med 10: 1-7
< Y, Zhu L, Li Y, Ji J, Li J, Yuan F, Wang D, Chen W, Huang O, Chen X, Wu J, Shen K, Loo WTY, Chow LWC https://doi.org/10.1186/1479-5876-10-S1-S4>
41. 2016: Epithelial cell adhesion molecule expression in canine tumours. J Comp Pathol 155: 299-304
< DH, Hayes DF, Meuten T, Laver T, Thomas DG https://doi.org/10.1016/j.jcpa.2016.07.010>
42. 2013: Epithelial cell adhesion molecule (EpCAM) regulates claudin dynamics and tight junctions. J Biol Chem 288: 12253-12268
< CJ, Mannan P, Lu M, Udey MC https://doi.org/10.1074/jbc.M113.457499>
43. 2017: Mesenchymal phenotype of circulating tumor cells is associated with distant metastasis in breast cancer patients. Cancer Manag Res 9: 691-700
< S, Tiecheng W, Peng X, Liu J, Liu F, Wu S, Liu S, Dong Y, Xie S, Ma S https://doi.org/10.2147/CMAR.S149801>